Natco Pharma Ltd NATCOPHARM-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:29 PM IST
851.55quote price arrow up+17.75 (+2.13%)
Volume
1,844,515
52 week range
402.55 - 996.00

...

Loading . . .

KEY STATS

  • Open838.15
  • Day High898.80
  • Day Low838.15
  • Prev Close833.80
  • 52 Week High996.00
  • 52 Week High Date12/07/20
  • 52 Week Low402.55
  • 52 Week Low Date03/25/20
  • Market Cap2,078.09M
  • Shares Out182.19M
  • 10 Day Average Volume519,416.09
  • Dividend6.25
  • Dividend Yield0.73%
  • Beta
  • 1 Year % Change41.28

RATIOS/PROFITABILITY

  • EPS (TTM)26.48
  • P/E (TTM)32.16
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/22/2021
  • Div Amount1.00
  • Split Date-
  • Split Factor-

Latest Natco Pharma Ltd News

There is no recent news for this security.

Latest NATCOPHARM-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include...
V. Nannapaneni
Chairman
Rajeev Nannapaneni
Chief Executive Officer
S. V. V. N. Appa Rao
Chief Financial Officer
P. S. R. K. Prasad
Executive Vice President
Address
Natco House, Road No 2, Banjara Hills
Hyderabad
500034
India